222 related articles for article (PubMed ID: 33326598)
1. A non-convulsant delta-opioid receptor agonist, KNT-127, reduces cortical spreading depression and nitroglycerin-induced allodynia.
Bertels Z; Witkowski WD; Asif S; Siegersma K; van Rijn RM; Pradhan AA
Headache; 2021 Jan; 61(1):170-178. PubMed ID: 33326598
[TBL] [Abstract][Full Text] [Related]
2. Forebrain delta opioid receptors regulate the response of delta agonist in models of migraine and opioid-induced hyperalgesia.
Dripps IJ; Bertels Z; Moye LS; Tipton AF; Siegersma K; Baca SM; Kieffer BL; Pradhan AA
Sci Rep; 2020 Oct; 10(1):17629. PubMed ID: 33077757
[TBL] [Abstract][Full Text] [Related]
3. δ-Opioid receptor agonists inhibit migraine-related hyperalgesia, aversive state and cortical spreading depression in mice.
Pradhan AA; Smith ML; Zyuzin J; Charles A
Br J Pharmacol; 2014 May; 171(9):2375-84. PubMed ID: 24467301
[TBL] [Abstract][Full Text] [Related]
4. In vivo properties of KNT-127, a novel δ opioid receptor agonist: receptor internalization, antihyperalgesia and antidepressant effects in mice.
Nozaki C; Nagase H; Nemoto T; Matifas A; Kieffer BL; Gaveriaux-Ruff C
Br J Pharmacol; 2014 Dec; 171(23):5376-86. PubMed ID: 25048778
[TBL] [Abstract][Full Text] [Related]
5. Delta opioid receptors in Nav1.8 expressing peripheral neurons partially regulate the effect of delta agonist in models of migraine and opioid-induced hyperalgesia.
Bertels Z; Dripps IJ; Shah P; Moye LS; Tipton AF; Siegersma K; Pradhan AA
Neurobiol Pain; 2022; 12():100099. PubMed ID: 35859654
[TBL] [Abstract][Full Text] [Related]
6. A selective delta opioid receptor agonist SNC80, but not KNT-127, induced tremor-like behaviors via hippocampal glutamatergic system in mice.
Sakamoto K; Yamada D; Yamanaka N; Nishida M; Iio K; Nagase H; Saitoh A
Brain Res; 2021 Apr; 1757():147297. PubMed ID: 33516811
[TBL] [Abstract][Full Text] [Related]
7. Selective agonists of the δ-opioid receptor, KNT-127 and SNC80, act differentially on extinction learning of contextual fear memory in mice.
Yamada D; Yanagisawa S; Yoshizawa K; Yanagita S; Oka JI; Nagase H; Saitoh A
Neuropharmacology; 2019 Dec; 160():107792. PubMed ID: 31553899
[TBL] [Abstract][Full Text] [Related]
8. Effects of the delta opioid receptor agonist KNT-127 on electroencephalographic activity in mice.
Saitoh A; Tominaga H; Ogawa Y; Irukayama-Tomobe Y; Yamada M; Yanagisawa M; Nagase H
Pharmacol Rep; 2018 Apr; 70(2):350-354. PubMed ID: 29477045
[TBL] [Abstract][Full Text] [Related]
9. Sumatriptan alleviates nitroglycerin-induced mechanical and thermal allodynia in mice.
Bates EA; Nikai T; Brennan KC; Fu YH; Charles AC; Basbaum AI; Ptácek LJ; Ahn AH
Cephalalgia; 2010 Feb; 30(2):170-8. PubMed ID: 19489890
[TBL] [Abstract][Full Text] [Related]
10. Delta opioid receptor agonists are effective for multiple types of headache disorders.
Moye LS; Tipton AF; Dripps I; Sheets Z; Crombie A; Violin JD; Pradhan AA
Neuropharmacology; 2019 Apr; 148():77-86. PubMed ID: 30553828
[TBL] [Abstract][Full Text] [Related]
11. The novel δ opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions.
Saitoh A; Sugiyama A; Nemoto T; Fujii H; Wada K; Oka J; Nagase H; Yamada M
Behav Brain Res; 2011 Oct; 223(2):271-9. PubMed ID: 21565223
[TBL] [Abstract][Full Text] [Related]
12. Utility of different outcome measures for the nitroglycerin model of migraine in mice.
Farkas S; Bölcskei K; Markovics A; Varga A; Kis-Varga Á; Kormos V; Gaszner B; Horváth C; Tuka B; Tajti J; Helyes Z
J Pharmacol Toxicol Methods; 2016; 77():33-44. PubMed ID: 26456070
[TBL] [Abstract][Full Text] [Related]
13. Delta Opioid Receptor (DOR) Ligands and Pharmacology: Development of Indolo- and Quinolinomorphinan Derivatives Based on the Message-Address Concept.
Saitoh A; Nagase H
Handb Exp Pharmacol; 2018; 247():3-19. PubMed ID: 27787711
[TBL] [Abstract][Full Text] [Related]
14. The development of a mouse model of mTBI-induced post-traumatic migraine, and identification of the delta opioid receptor as a novel therapeutic target.
Moye LS; Novack ML; Tipton AF; Krishnan H; Pandey SC; Pradhan AA
Cephalalgia; 2019 Jan; 39(1):77-90. PubMed ID: 29771142
[TBL] [Abstract][Full Text] [Related]
15. The delta opioid receptor agonist KNT-127 in the prelimbic medial prefrontal cortex attenuates veratrine-induced anxiety-like behaviors in mice.
Saitoh A; Suzuki S; Soda A; Ohashi M; Yamada M; Oka JI; Nagase H; Yamada M
Behav Brain Res; 2018 Jan; 336():77-84. PubMed ID: 28864205
[TBL] [Abstract][Full Text] [Related]
16. Delta Opioid Receptor Agonists Ameliorate Colonic Inflammation by Modulating Immune Responses.
Nagata K; Nagase H; Okuzumi A; Nishiyama C
Front Immunol; 2021; 12():730706. PubMed ID: 34630408
[TBL] [Abstract][Full Text] [Related]
17. Neuronal complexity is attenuated in preclinical models of migraine and restored by HDAC6 inhibition.
Bertels Z; Singh H; Dripps I; Siegersma K; Tipton AF; Witkowski WD; Sheets Z; Shah P; Conway C; Mangutov E; Ao M; Petukhova V; Karumudi B; Petukhov PA; Baca SM; Rasenick MM; Pradhan AA
Elife; 2021 Apr; 10():. PubMed ID: 33856345
[TBL] [Abstract][Full Text] [Related]
18. Delta-opioid receptors as targets for migraine therapy.
Charles A; Pradhan AA
Curr Opin Neurol; 2016 Jun; 29(3):314-9. PubMed ID: 27023737
[TBL] [Abstract][Full Text] [Related]
19. Modulation of glutamatergic synaptic transmission and neuronal excitability in the prelimbic medial prefrontal cortex via delta-opioid receptors in mice.
Yamada D; Takahashi J; Iio K; Nagase H; Saitoh A
Biochem Biophys Res Commun; 2021 Jun; 560():192-198. PubMed ID: 34000468
[TBL] [Abstract][Full Text] [Related]
20. The novel δ opioid receptor agonist KNT-127 produces distinct anxiolytic-like effects in rats without producing the adverse effects associated with benzodiazepines.
Saitoh A; Sugiyama A; Yamada M; Inagaki M; Oka J; Nagase H; Yamada M
Neuropharmacology; 2013 Apr; 67():485-93. PubMed ID: 23246531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
